Search clinical trials for: Nifedipine GITS (Adalat LA, BAYA1040)

Total 54 results

Bayer

Completed

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension (DISTINCT)

Hypertension, Essential

Spain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
Bayer

Completed

Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study

Hypertension

Japan
SocraTec R&D GmbH
SocraMetrics GmbH

Completed

Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions

Bioavailability, Therapeutical Indication Not Studied

Germany
Bayer

Completed

Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study (ADRENAL)

Hypertension

China
Bayer

Completed

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy. (ADEPT)

Hypertension

China
Bayer

Completed

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Hypertension, Essential

Germany
Bayer

Completed

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Hypertension

Korea, Republic of
Bayer

Completed

Treatment of Hypertension With Adalat® in Combination With Other Drugs

Hypertension

Saudi Arabia, Jordan, Lebanon, Russian Federation, Bahrain, Egypt, United Arab Emirates, Morocco, Oman, Qatar, Pakistan
Bayer

Completed

High Dose BAYA1040 CR: a Long Term Extension Study

Hypertension

Japan
Bayer

Completed

Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

Hypertension

Japan
Bayer

Completed

Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension

Hypertension

United Kingdom
Bayer

Completed

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

Hypertension

Japan
Bayer

Completed

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

Hypertension

Japan
Bayer

Completed

Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.

Clinical Pharmacology

Germany
Bayer

Completed

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

Hypertension

Japan
Cao Yu

Unknown

Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects

Therapeutic Equivalency

China
Guangzhou First People's Hospital

Unknown

The Pharmacokinetics of Nifedipine Controlled Release Tablets in Hypertensive Patients on Hemodialysis (PICASSO)

Hypertension on Chronic Maintenance Hemodialysis

China
Jing Liu
Bayer

Terminated

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness (NARRAS)

Hypertension

China
Bayer

Completed

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Hypertension

China, Korea, Republic of
Shanghai Jiao Tong University School of Medicine

Completed

Amlodipine Prevents Morning Blood Pressure Surge Study (ARMORS)

Hypertension

China
Peking University First Hospital
Bayer

Unknown

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Hypertension

China
National Taiwan University Hospital

Unknown

A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension

Hypertension

Taiwan
Bayer

Withdrawn

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

Hypertension

Italy
Reig Jofre Group

Completed

Bioavailability Of A Single Dose Of Nifedipine Oral Solution Compared To Adalat Capsules In Healthy Female Volunteers (NIFEPAR_PK1)

Bioequivalence

Spain
University of Edinburgh
Encysive Pharmaceuticals

Unknown

Sitaxsentan in Proteinuric Chronic Kidney Disease

Proteinuria | Chronic Kidney Disease | Blood Pressure

United Kingdom
Shanghai Shyndec Pharmaceutical Co., Ltd.

Completed

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Essential Hypertension

China
Shanghai Shyndec Pharmaceutical Co., Ltd.

Unknown

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure

Essential Hypertension

China
Istituto Auxologico Italiano
Bayer

Completed

REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial (REVERENT)

Hypertension | High Blood Pressure Variability

China, Greece, Italy
The Baruch Padeh Medical Center, Poriya

Terminated

Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery

Preterm Labor
University of Southern Denmark

Completed

Role of Calcium Channels in Vascular Function

Endothelium, Vascular

Denmark
Bayer

Completed

Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed

Hypertension, Essential

Germany
Actavis Inc.

Completed

A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions

Healthy

United States
Bayer

Completed

Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

Hypertension

Germany, United States, Canada, Poland, United Kingdom, Belgium
Actavis Inc.

Completed

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions

Healthy

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study To Test The Effect Of Apatinib On P450 Enzymes

Cytochrome P450 Interaction

China
Baskent University

Completed

Losartan Therapy in Pulmonary Hypertension

Pulmonary Hypertension
Queen Mary University of London

Active, not recruiting

Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism

Primary Aldosteronism | Endocrine Hypertension

United Kingdom
Samuel Lunenfeld Research Institute, Mount Sinai...

Completed

Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia

Hypertension | Pregnancy | Pre-Eclampsia

Canada
American University of Beirut Medical Center

Terminated

Two Dose Regimens of Nifedipine for the Management of Preterm Labor

Labor, Premature

Lebanon
Chantal Csajka

Unknown

Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Acute Threatened Preterm Labour

Preterm Labor

Switzerland
Indiana University

Completed

Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor

Preterm Labor

United States
Bayer

Withdrawn

Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients (CARDINAL)

Hypertension | Diabetic Nephropathies
Istituto Auxologico Italiano
Bayer

Completed

HIGH Altitude CArdiovascular REsearch in the ANDES (HIGHCARE-A)

Hypertension | High Altitude

Peru
Novartis

Completed

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients (EXAM)

Hypertension

China
University of Calgary

Recruiting

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

Epilepsy | Epilepsies, Partial

Canada
University of Alabama at Birmingham
Medical University of South Carolina; Johns Hopkins University; University of... and other collaborators

Completed

Chronic Hypertension and Pregnancy (CHAP) Project (CHAP)

Hypertension

United States
University of Edinburgh
British Heart Foundation

Completed

Endothelin Receptor Antagonism in Proteinuric Nephropathy

Proteinuria | Chronic Kidney Disease

United Kingdom
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Drug Discrimination in Methadone-Maintained Humans Study 3 (OMDD3)

Drug Dependence

United States
Maastricht University Medical Center

Recruiting

Early Vascular Adjustments During Hypertensive Pregnancy (EVA)

Pre-Eclampsia | Hypertension, Pregnancy-Induced

Netherlands
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Drug Discrimination in Methadone-Maintained Humans Study 2 (OMDD2)

Opioid Dependence

United States

3

Subscribe